Shlokka Dyes IPO funds draw CRISIL scrutiny in 2026

Stock snapshot and what investors are reacting to

Shlokka Dyes Limited (BSE: 544582) has come into focus after a monitoring agency report linked to its IPO proceeds raised governance and compliance questions. In one market update, the stock was shown trading at ₹23.89, up 3.87% on the day, with an intraday range of ₹23.50 to ₹23.89 and volume of 6,000 shares. The same update listed a 52-week high of ₹23.89 and a 52-week low of ₹23.50.

Another market screen for the same company showed a different snapshot: ₹21.73 at 4:00 PM on March 30, down 4.73%, and a 52-week high of ₹90 with a 52-week low of ₹21.67. These differing figures reflect that multiple data snapshots were presented in the source material, likely from different dates or feeds, and should be read accordingly.

What the Regulation 30 filing was about

A BSE announcement referenced an “Announcement under Regulation 30 (LODR) - Monitoring Agency Report,” stating that the monitoring agency report was enclosed. The monitoring agency in the material is CRISIL Ratings Limited, appointed to track utilisation of IPO proceeds under the applicable framework.

Monitoring agency reports are meant to give investors a structured view of whether issue proceeds are being used for the purposes stated in the offer documents. When a report is qualified or highlights deviations, it typically becomes a point of scrutiny for investors because it raises questions around controls, documentation, and execution.

CRISIL’s key observations: deviations and pending reconciliations

As per the material, Shlokka Dyes came under scrutiny after CRISIL reported significant deviations in how IPO funds were utilised. Based on data as of December 2025 and March 2026, the report highlighted pending recovery or reconciliation of ₹18.72 crore. It also stated that a further ₹1.00 crore remained outstanding as of March 2026.

Separately, the company was reported to have exceeded its working capital allocation by ₹12.57 crore. The same set of details also mentioned unspecified expenditures totalling ₹0.56 crore. The material attributed the issues to unauthorised fund transfers from designated IPO accounts and delays in project implementation.

“Issuer not cooperating” and limits of independent verification

The source also described a “Qualified Monitoring Agency Report - Issuer Not Cooperating” for the quarter ended December 31, 2025, pursuant to Regulation 262(2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. In this description, CRISIL indicated it could not perform its duties effectively because Shlokka Dyes failed to provide necessary information and documents required for monitoring.

The key implication of an “issuer not cooperating” status is that the monitoring agency is unable to independently verify actual utilisation against stated objects. The report description also said stakeholders should exercise due caution when relying on such a qualified report because the monitoring agency could not provide a comprehensive assessment.

IPO size, timing, and stated objects of the issue

The material states Shlokka Dyes raised ₹57.79 crore through its IPO, with the IPO prospectus dated October 15, 2025. It also notes an IPO plan of 63,50,400 equity shares in a price band of ₹95 to ₹100 per share, with the issue opening on September 30, 2025 and closing on October 6, 2025. Another line listed the issue period as September 30, 2025 to October 14, 2025.

Planned deployment of IPO proceeds, as provided in the material, included plant and machinery of ₹6.13 crore, debt repayment of ₹11.50 crore, working capital of ₹28.00 crore, general corporate purposes of ₹6.77 crore, and offer expenses of ₹5.39 crore. These add up to ₹57.79 crore, matching the stated proceeds amount.

Unutilised proceeds and legal response noted in the material

As of March 2026, ₹3.89 crore of IPO proceeds remained unutilised, according to the source. Alongside the monitoring agency findings, the material says the company initiated legal action in response.

No further details were provided on the nature of the legal proceedings, the forum, or the relief sought. The key disclosed point is that a legal step was initiated after the monitoring agency findings were reported.

Business profile and operating context

Shlokka Dyes Limited manufactures and sells reactive dyes in India. The product list in the material includes direct, basic, vat, digital printing, paper, and other dyes, serving industries such as textiles, leather, paper, and paints. Reactive dyes were described as a category of synthetic organic dyes extensively used in the textile industry.

This sector context matters because working capital needs, raw material procurement cycles, and compliance with customer specifications can be sensitive to project execution and fund controls. The monitoring agency concerns, as described, therefore intersect with both governance and operational execution.

Key financial and market metrics mentioned

The source included multiple metric snapshots, including a Price-to-Earnings ratio of 7.8x (stated as below the Indian market at 23.3x). Another market summary listed P/E at 4.65 and P/B at 0.55. A dataset also listed Market cap at ₹51.51 crore, earnings (TTM) at ₹6.62 crore, and revenue (TTM) at ₹91.95 crore.

Margin and leverage indicators in the material included gross margin of 16.96%, net profit margin of 7.20%, and a debt-to-equity ratio of 98.5%. The last reported earnings date was listed as September 30, 2025.

Summary table: IPO proceeds, deviations, and key datapoints

Market impact and why the monitoring report matters

The immediate market impact in the material is the heightened scrutiny and the presence of a qualified monitoring agency report. For investors, the core issue is not just the size of deviations but whether documentation, internal approvals, and designated-account controls functioned as intended.

A monitoring report that is qualified due to non-cooperation also changes how investors interpret subsequent disclosures. If the monitoring agency could not verify utilisation, the burden shifts back to the company’s own disclosures and any clarifications it provides through stock exchange filings.

Conclusion

Shlokka Dyes’ monitoring agency disclosures put the spotlight on IPO proceeds tracking, including reported deviations, pending reconciliation amounts, and CRISIL’s “issuer not cooperating” qualification for the quarter ended December 31, 2025. The company’s IPO raised ₹57.79 crore and the stated objects covered capex, debt repayment, and working capital, but the monitoring notes cited issues such as pending recovery and an overshoot in working capital deployment.

The next set of clarity points for investors will depend on any further exchange filings, additional monitoring updates, and the outcome of the legal action the company said it initiated in response to the findings.